SCHEMBL11895561

SCHEMBL11895561

OB(O)c1c(-c2ccccc2)cccc1-c1cccc2c1sc1ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.51
▸ PARP14 Q460N5 1/20 0.48
▸ F9 P00740 1/20 0.41
▸ TNKS O95271 1/20 0.38
▸ TNKS2 Q9H2K2 1/20 0.38
▸ GPR3 P46089 1/20 0.38
▸ PRKDC P78527 6/20 0.38
▸ SLC9A1 P19634 2/20 0.37
▸ LIMK1 P53667 2/20 0.37
▸ PIK3CD O00329 2/20 0.36
▸ PIK3CB P42338 2/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ PIK3CG P48736 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ BRDT Q58F21 1/20 0.36
▸ MAPT P10636 1/20 0.33
▸ ADK P55263 1/20 0.33
▸ PDCD1 Q15116 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29072912 0.84 ALOX5 (0.55) ALOX5PARP14F9TNKSTNKS2
SCHEMBL16182150 0.84 ALOX5 (0.55) ALOX5PARP14F9TNKSTNKS2
SCHEMBL2810404 0.84 ALOX5 (0.63) ALOX5PARP14F9TNKSTNKS2
SCHEMBL29362337 0.84 ALOX5 (0.63) ALOX5PARP14F9TNKSTNKS2
SCHEMBL28703605 0.82 ALOX5 (0.49) ALOX5PARP14F9TNKSTNKS2
SCHEMBL17117671 0.80 ALOX5 (0.64) ALOX5PARP14F9TNKSTNKS2
SCHEMBL30150735 0.80 ALOX5 (0.64) ALOX5PARP14F9TNKSTNKS2
SCHEMBL18435735 0.80 ALOX5 (0.64) ALOX5PARP14F9TNKSTNKS2
SCHEMBL515355 0.80 ALOX5 (0.60) ALOX5PARP14F9TNKSTNKS2
SCHEMBL29427624 0.80 ALOX5 (0.60) ALOX5PARP14F9TNKSTNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9067916-B2 Heterocyclic compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-06-30 — — US disclosed
US-20120197020-A1 HETEROCYCLIC COMPOUND SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-08-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120197020-A1 HETEROCYCLIC COMPOUND CCNA1, CRY1, CCNT1 ALOX5 2818/4885PARP14 1562/4885F9 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback